Nothing Special   »   [go: up one dir, main page]

AU4860900A - Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells - Google Patents

Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells

Info

Publication number
AU4860900A
AU4860900A AU48609/00A AU4860900A AU4860900A AU 4860900 A AU4860900 A AU 4860900A AU 48609/00 A AU48609/00 A AU 48609/00A AU 4860900 A AU4860900 A AU 4860900A AU 4860900 A AU4860900 A AU 4860900A
Authority
AU
Australia
Prior art keywords
cryopreservation
isolation
methods
epithelial cells
therapeutic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48609/00A
Inventor
Allan L. Goldstein
Valerie W. Hu
Peter D. Prestidge
Jonathan M. Sackier
Gordon Wigginton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIFEBANK SERVICES LLC
Original Assignee
LIFEBANK SERVICES LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIFEBANK SERVICES LLC filed Critical LIFEBANK SERVICES LLC
Publication of AU4860900A publication Critical patent/AU4860900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dentistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU48609/00A 1999-06-02 2000-06-01 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells Abandoned AU4860900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13774099P 1999-06-02 1999-06-02
US60137740 1999-06-02
PCT/US2000/040052 WO2000073421A2 (en) 1999-06-02 2000-06-01 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells

Publications (1)

Publication Number Publication Date
AU4860900A true AU4860900A (en) 2000-12-18

Family

ID=22478856

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48609/00A Abandoned AU4860900A (en) 1999-06-02 2000-06-01 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells

Country Status (2)

Country Link
AU (1) AU4860900A (en)
WO (1) WO2000073421A2 (en)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1004204B (en) * 1999-09-29 2003-09-05 Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses
US7118845B2 (en) 2000-06-15 2006-10-10 3M Innovative Properties Company Multiphoton photochemical process and articles preparable thereby
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
CA2430989A1 (en) 2000-12-06 2002-06-13 Robert J. Hariri Method of collecting placental stem cells
ES2549161T3 (en) * 2001-02-14 2015-10-23 Anthrogenesis Corporation Postpartum mammalian placenta, its use and placental stem cells thereof
EP2316918B1 (en) 2001-02-14 2015-07-01 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
DE60233248D1 (en) 2001-11-15 2009-09-17 Childrens Medical Center PROCESS FOR THE ISOLATION, EXPANSION AND DIFFERENTIATION OF FEDERAL STRAIN CELLS FROM CHORION ZOTTE, FRUIT WATER AND PLAZENTA AND THERAPEUTIC USES THEREOF
AU2002354101A1 (en) * 2001-12-06 2003-06-17 Sankyo Company, Limited Medicinal compositions containing human amnion-origin cells
EP2186407A1 (en) 2002-02-13 2010-05-19 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
US8062837B2 (en) 2002-02-14 2011-11-22 Stemcyte, Inc. Plasma-depleted, not erythrocyte-depleted, cord blood compositions and method of making
US7498171B2 (en) 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
WO2003089619A2 (en) * 2002-04-19 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Placental derived stem cells and uses thereof
US20040161419A1 (en) * 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
AU2003254298A1 (en) 2002-08-02 2004-02-23 Stratatech Corporation Species specific dna detection
KR20050086780A (en) 2002-11-26 2005-08-30 안트로제네시스 코포레이션 Cytotherapeutics, cytotherapeutic units and methods for treatments using them
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
ES2564044T3 (en) 2003-06-27 2016-03-17 DePuy Synthes Products, Inc. Postpartum cells derived from umbilical cord tissue and methods of preparing and using them
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
ATE510005T1 (en) 2003-06-27 2011-06-15 Univ Laval METHOD FOR ISOLATION OF CELLS FROM THE UMBILE CORD
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US20060216821A1 (en) 2004-02-26 2006-09-28 Reliance Life Sciences Pvt. Ltd. Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof
US8187875B2 (en) 2004-02-26 2012-05-29 Reliance Life Sciences Pvt. Ltd. Dopaminergic neurons derived from corneal limbus, methods of isolation and uses thereof
JP2006006249A (en) * 2004-06-28 2006-01-12 Hiroshima Univ Method for culturing amnion-derived cell and utilization of the same
NZ553695A (en) * 2004-08-16 2009-10-30 Cellres Corp Pte Ltd Isolation of stem/progenitor cells from amniotic membrane of umbilical cord
AU2005322133B2 (en) 2004-12-23 2011-06-30 Ethicon Incorporated Treatment of Parkinson's disease and related disorders using postpartum derived cells
US20060222634A1 (en) 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
US8153430B2 (en) 2005-03-31 2012-04-10 Stemnion, Inc. Methods related to surgery
US8048619B2 (en) 2005-06-02 2011-11-01 Stemcyte, Inc. Method of treating a hematopoietic associated disease or disorder with plasma-depleted, but not erythrocyte-depleted cord blood compositions
PL1957633T3 (en) 2005-10-13 2014-05-30 Anthrogenesis Corp Immunomodulation using placental stem cells
US8287854B2 (en) 2005-10-21 2012-10-16 Cellresearch Corporation Pte Ltd Skin equivalents derived from umbilical cord mesenchymal stem/progenitor cells and umbilical cord epithelial stem/progenitor cells
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
WO2007070870A1 (en) 2005-12-16 2007-06-21 Ethicon, Inc. Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
JP2009521930A (en) 2005-12-29 2009-06-11 アントフロゲネシス コーポレーション Co-culture of placental stem cells and stem cells derived from a second source
AU2006332680A1 (en) * 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
KR101900809B1 (en) 2005-12-29 2018-09-20 안트로제네시스 코포레이션 Placental stem cell populations
US8871198B2 (en) 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
US8338175B2 (en) 2006-02-24 2012-12-25 Reliance Life Sciences Pvt. Ltd. Conjunctival tissue system
ES2572214T3 (en) 2006-03-23 2016-05-30 Pluristem Ltd Methods for cell expansion and uses of cells and conditioned media produced in this way for therapy
WO2008003042A2 (en) * 2006-06-28 2008-01-03 The University Of Medicine And Dentistry Of New Jersey Amnion-derived stem cells and uses thereof
US8221741B2 (en) 2007-01-17 2012-07-17 Marshall Vivienne S Methods for modulating inflammatory and/or immune responses
US8506949B2 (en) 2007-01-17 2013-08-13 Stemnion, Inc. Methods for modulating inflammatory and/or immune responses
EP2129775A1 (en) 2007-02-12 2009-12-09 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
EP3103462A1 (en) 2007-02-12 2016-12-14 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
EP2139497B1 (en) 2007-04-13 2013-11-06 Stemnion, INC. Methods for treating nervous system injury and disease
WO2008144820A1 (en) * 2007-05-28 2008-12-04 Monash University Treatment of chronic lung disease
JP5597129B2 (en) 2007-06-18 2014-10-01 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド Method for isolating placenta-derived stem cells and precursor cells
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
PL2203176T3 (en) 2007-09-28 2015-05-29 Anthrogenesis Corp Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
US20090136471A1 (en) 2007-11-07 2009-05-28 Anthrogenesis Corporation Treatment of premature birth complications
CN102186338B (en) 2008-08-20 2016-03-16 人类起源公司 The cell composition improved and prepare the method for described composition
ES2749500T3 (en) 2008-11-19 2020-03-20 Celularity Inc Adherent cells derived from amnion
JP5518893B2 (en) 2008-12-19 2014-06-11 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー Treatment of lungs and lung diseases and disorders
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
EP2411504B1 (en) 2009-03-26 2017-05-10 DePuy Synthes Products, Inc. Human umbilical cord tissue cells as therapy for alzheimer's disease
DK3284818T3 (en) 2010-01-26 2022-06-20 Celularity Inc Treatment of bone-related cancer using placenta stem cells
IL250234B2 (en) 2010-04-07 2023-10-01 Anthrogenesis Llc Angiogenesis using placental stem cells
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8840665B2 (en) 2010-06-11 2014-09-23 Liventa Bioscience, Inc. Method of tendon repair with amnion and chorion constructs
CA2804750C (en) 2010-07-13 2022-05-10 Anthrogenesis Corporation Methods of generating natural killer cells
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
JP6104896B2 (en) 2011-06-01 2017-03-29 アントフロゲネシス コーポレーション Treatment of pain using placental stem cells
WO2013079701A2 (en) 2011-11-30 2013-06-06 University Of Bremen Expression of mirnas in placental tissue
AU2012358810B2 (en) 2011-12-23 2018-03-15 DePuy Synthes Products, Inc. Detection of human umbilical cord tissue-derived cells
CA2863795A1 (en) 2012-02-13 2013-08-22 Gamida-Cell Ltd. Culturing of mesenchymal stem cells
US8961617B2 (en) 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
EP2953635A4 (en) 2013-02-05 2016-10-26 Anthrogenesis Corp Natural killer cells from placenta
US20150079061A1 (en) * 2013-07-12 2015-03-19 Patrick J. Casey Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
CN103725643B (en) * 2013-12-30 2015-12-30 厦门大学 A kind of method building tissue engineering comea endothelium
CN103966159B (en) * 2014-02-13 2015-08-05 天津和泽干细胞科技有限公司 Human plactnta Subaerial blue green algae and stem cell bank construction process thereof
US10765705B2 (en) 2014-11-24 2020-09-08 Prime Merger Sub, Llc Visco-supplement compositions, and methods of use thereof
EP3297694A1 (en) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
CN106566798A (en) * 2016-11-08 2017-04-19 华南生物医药研究院 Method for getting amniotic epithelial stem cells and kit
CN111518747A (en) * 2020-04-30 2020-08-11 成都容医汇生物技术研究院 Method for separating and extracting amniotic stem cells from placenta

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD225440B1 (en) * 1984-03-27 1988-09-14 Adw Ddr CELL MEDIUM BREED
US4975365A (en) * 1987-05-12 1990-12-04 The John Hopkins University Assay for measuring DNA cell repair potential
GB8803697D0 (en) * 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
US5340740A (en) * 1992-05-15 1994-08-23 North Carolina State University Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
JP3806189B2 (en) * 1995-07-27 2006-08-09 株式会社エスアールエル Methods for gene transfer into human amniotic cells and methods for preparing cells for gene therapy
US6117676A (en) * 1995-07-27 2000-09-12 Srl, Inc. Transfected human amniotic cells and method for producing a gene product
WO1997026902A1 (en) * 1996-01-23 1997-07-31 Srl, Inc. Cells for treating dementia
US6152142A (en) * 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries

Also Published As

Publication number Publication date
WO2000073421A3 (en) 2001-04-26
WO2000073421A2 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
AU4860900A (en) Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells
AU5774200A (en) Intelligent splitter, system, and methods of use
AU3884701A (en) Cardiac methods and system
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
IL201916A (en) Human placental stem cells, characteristics, preparation and use thereof
AU3956900A (en) Substituted imidazoles, their preparation and use
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU2002356861A1 (en) Fibrin membrane and methods for its preparation- application to artificial skin
AU6549898A (en) Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina
AU2002322211A1 (en) Methods and compisitions for activation human t cells in vitro
AU2001260847A1 (en) Compositions isolated from skin cells and methods for their use
AU3033100A (en) Substituted imidazoles, their preparation and use
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU3730600A (en) Compositions preparations and uses of human papillomavirus l1 protein
AU715620C (en) Therapeutic methods and uses
AU1164601A (en) Therapeutic use and formulation
AU5886500A (en) Indolyl-benzimidazole antibacterials, and methods of use thereof
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
AU8038998A (en) Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
AU7437900A (en) Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and others uses
AU2067501A (en) Human oxidoreductase proteins
AU1911301A (en) Novel bacterial isolate and the preparation and use of its active metabolites
AU2002216223A1 (en) Preservation of cells
AU3501700A (en) Human endokine alpha and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase